Skip to content
Research Article Open access CC BY 4.0

Therapeutic Targets In Breast Cancer Signaling: A Review

Emmanuel I. Obeagu, Quratulain Babar, C. C. N. Vincent, Chikwendu Lawrence Udenze, Richard I. Eze, Chukwum J. Okafor, Bart I. Ifionu, Augustine Amaeze Amaeze, Florence Ngozi Amaeze

Journal of Pharmaceutical Research International · pp. 82–99 · Published 13 Dec 2021

10.9734/jpri/2021/v33i56A33889

Abstract

For women, the most dominant type of cancer is breast cancer and perhaps one of the most recognizedreasons of death. This is a disorder of many distinct traits, many of which are known as positive hormone receptor, human epidermal receptor-2 (HER2+), and three negative breast cancers (TNBC). Drugs that directly target and kill tumors constitute a rapidly-growing form of molecular therapy for cancer patients. Analysis reveals that stable breast tissue cells exhibit receptors which aren't usually present. As a result, it is imperative to cognize the molecular roots of breast cancer and the myriad compromised pathology-related processes and pathways to ensure progresses in early diagnosis and prevention. This study demonstrates essential cellular pathways relevant for breast cancer including improvements in cell proliferation, apoptosis, and hormone balances in breast tissues. On the basis of these notions, we consider how breast cancer is associated to the creation of potentially therapeutic interventions and predictive biomarkers.

Breast cancer tumor apoptosis cell proliferation

Cited by 63

Assessment of nurses' perception of role of genetics in development of breast cancer at Federal Teaching Hospital, Ido-Ekiti

Agatha Ogunkorode, Oluwabunmi Mercy Adeniji, Deborah Tolulope Esan · Revista de Senología y Patología Mamaria · 2022

Harnessing BRCA Advances: Revolutionizing Breast Cancer Diagnosis and Treatment

Emmanuel Ifeanyi Obeagu · Haematology International Journal · 2024

Beyond Blood Counts: Hematocrit Dynamics in Breast Cancer Monitoring

Obeagu E.I., Aja Pm · KIU Journal of Health Sciences · 2023

Evaluation of the Care Pathway for Breast Cancer Patients: Post-operative Length of Stay as an Indicator of Performance

Antonio D’Amore, Mimmo De Francesco, Andrea Fidecicchi · Lecture notes in bioengineering · 2025

Study of Anticancer Activity of Active Form of Vitamin D Analogs Against Brca-1 and Brca-2 Based on Molecular Docking and DFT Method

Sabrina Helen, M. Abul Kashem Liton, Arabina Akter Pothi · Oriental Journal Of Chemistry · 2025

Breast Cancer: A Multifactorial Disease with Emerging Precision Medicine Approaches

Ruchi Rana, Puneet Puneet, Gurinder Singh · International Journal of Scientific Research in Science and Technology · 2025

Showing 34 of 63 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

3

Page views

0

PDF downloads

0

Outbound clicks

63

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.